Miguel F Segura (Miguel Segura)

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 33

Top Venues

Cancers

Clinical and translational medicine

PloS one

Cell death & disease

Vall d'Hebron Institut de Recerca

Universitat de Lleida (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Vall d'Hebron Institut de Recerca Jan 30 2012

Spain

Head of the Laboratory of Neural Tumors :: Oncology

New York University Mar 01 2007 - May 15 2012

United States

Postdoctoral Researcher :: Pathology

Education History

Universitat de Lleida Jul 01 2000 - May 02 2006

Spain

PHD :: Ciències Mèdiques Bàsiques

Publications

Catherine Murphy, Laura Devis-Jauregui, Ronja Struck, Ariadna Boloix, Ciara Gallagher, Cian Gavin, Federica Cottone, Aroa Soriano Fernandez, Stephen Madden, Josep Roma, Miguel F Segura, Olga Piskareva
In vivo cisplatin-resistant neuroblastoma metastatic model reveals tumour necrosis factor receptor superfamily member 4 (TNFRSF4) as an independent prognostic factor of survival in neuroblastoma. PloS one 19 (5) (2024)
Sunny Malhotra, Nicolas Fissolo, Carmen Rodríguez-Rivera, Enric Monreal, Marta Montpeyo, Elena Urcelay, Juan Carlos Triviño, María José Pérez-García, Miguel F Segura, Agustín Pappolla, Jordi Río, Andreu Vilaseca, José Ignacio Fernández Velasco, Andrés Miguez, Carlos Goicoechea, Marta Martinez-Vicente, Luisa M Villar, Xavier Montalban, Manuel Comabella Lopez
Clusterin deficiency is associated with a lack of response to teriflunomide in multiple sclerosis. Clinical and translational medicine 14 (4) (2024)
Sunny Malhotra, Nicolas Fissolo, Carmen Rodríguez-Rivera, Enric Monreal, Marta Montpeyo, Elena Urcelay, Juan Carlos Triviño, María José Pérez-García, Miguel F Segura, Agustín Pappolla, Jordi Río, Andreu Vilaseca, José Ignacio Fernández Velasco, Andrés Miguez, Carlos Goicoechea, Marta Martinez-Vicente, Luisa M Villar, Xavier Montalban, Manuel Comabella Lopez
Clusterin deficiency is associated with a lack of response to teriflunomide in multiple sclerosis. Clinical and translational medicine 14 (4) (2024)
Catherine Murphy, Laura Devis-Jauregui, Ronja Struck, Ariadna Boloix, Ciara Gallagher, Cian Gavin, Federica Cottone, Aroa Soriano Fernandez, Stephen Madden, Josep Roma, Miguel F Segura, Olga Piskareva
In vivo cisplatin-resistant neuroblastoma metastatic model reveals tumour necrosis factor receptor superfamily member 4 (TNFRSF4) as an independent prognostic factor of survival in neuroblastoma. PloS one 19 (5) (2024)
Marta Miera-Maluenda, María Pérez-Torres, Adriana Mañas, Alba Rubio-San-Simón, Maria Butjosa-Espín, Paula Ruiz-Duran, Jose A Seoane, Lucas Moreno, Miguel F Segura
Advances in the approaches used to repurpose drugs for neuroblastoma. Expert opinion on drug discovery (2024)
Sunny Malhotra, Nicolas Fissolo, Carmen Rodríguez-Rivera, Enric Monreal, Marta Montpeyo, Elena Urcelay, Juan Carlos Triviño, María José Pérez-García, Miguel F Segura, Agustín Pappolla, Jordi Río, Andreu Vilaseca, José Ignacio Fernández Velasco, Andrés Miguez, Carlos Goicoechea, Marta Martinez-Vicente, Luisa M Villar, Xavier Montalban, Manuel Comabella Lopez
Clusterin deficiency is associated with a lack of response to teriflunomide in multiple sclerosis. Clinical and translational medicine 14 (4) (2024)
Catherine Murphy, Laura Devis-Jauregui, Ronja Struck, Ariadna Boloix, Ciara Gallagher, Cian Gavin, Federica Cottone, Aroa Soriano Fernandez, Stephen Madden, Josep Roma, Miguel F Segura, Olga Piskareva
In vivo cisplatin-resistant neuroblastoma metastatic model reveals tumour necrosis factor receptor superfamily member 4 (TNFRSF4) as an independent prognostic factor of survival in neuroblastoma. PloS one 19 (5) (2024)
Guillem Pons, Gabriel Gallo-Oller, Natalia Navarro, Patricia Zarzosa, Júlia Sansa-Girona, Lia Garcia-Gilabert, Ainara Magdaleno, Miguel F Segura, Josep Sánchez de Toledo, Soledad Gallego Melcon, Lucas Moreno, Josep Roma
Analysis of Cancer Genomic Amplifications Identifies Druggable Collateral Dependencies within the Amplicon. Cancers 15 (6) (2023)
Guillem Pons, Gabriel Gallo-Oller, Natalia Navarro, Patricia Zarzosa, Júlia Sansa-Girona, Lia Garcia-Gilabert, Ainara Magdaleno, Miguel F Segura, Josep Sánchez de Toledo, Soledad Gallego Melcon, Lucas Moreno, Josep Roma
Analysis of Cancer Genomic Amplifications Identifies Druggable Collateral Dependencies within the Amplicon. Cancers 15 (6) (2023)
Carlos Jiménez, Lucas Moreno, Miguel F Segura
Epigenetic therapies for neuroblastoma: Immunogenicity awakens. Molecular oncology (2023)
Carlos Jiménez, Lucas Moreno, Miguel F Segura
Epigenetic therapies for neuroblastoma: immunogenicity awakens. Molecular oncology (2023)
Patricia Zarzosa, Lia Garcia-Gilabert, Raquel Hladun, Gabriela Guillén, Gabriel Gallo-Oller, Guillem Pons, Julia Sansa-Girona, Miguel F Segura, Josep Sánchez de Toledo, Lucas Moreno, Soledad Gallego Melcon, Josep Roma
Targeting the Hedgehog Pathway in Rhabdomyosarcoma. Cancers 15 (3) (2023)
Patricia Zarzosa, Lia Garcia-Gilabert, Raquel Hladun, Gabriela Guillén, Gabriel Gallo-Oller, Guillem Pons, Julia Sansa-Girona, Miguel F Segura, Josep Sánchez de Toledo, Lucas Moreno, Soledad Gallego Melcon, Josep Roma
Targeting the Hedgehog Pathway in Rhabdomyosarcoma. Cancers 15 (3) (2023)
Marc Masanas, Nuria Masiá, Leticia Suárez-Cabrera, Mireia Olivan, Aroa Soriano, Blanca Majem, Laura Devis-Jauregui, Rebeca Burgos-Panadero, Carlos Jiménez, Pau Rodriguez-Sodupe, Ariadna Boloix, Ignasi Toledano, Gabriela Guillén, Alexandra Navarro, David Llobet-Navas, Alberto Villanueva, Josep Sánchez de Toledo, Josep Roma, Rosa Noguera, Lucas Moreno, Rolf Krauss, Soledad Gallego, Anna Santamaria, Miguel F Segura
The oral KIF11 inhibitor 4SC-205 exhibits antitumor activity and potentiates standard and targeted therapies in primary and metastatic neuroblastoma models. Clinical and translational medicine 11 (10) (2022)
Carlos Jiménez, Roberta Antonelli, Mariona Nadal-Ribelles, Laura Devis-Jauregui, Pablo Latorre, Carme Solé, Marc Masanas, Adrià Molero-Valenzuela, Aroa Soriano Fernandez, Josep Sánchez de Toledo, David Llobet-Navàs, Josep Roma, Francesc Posas, Eulalia de Nadal, Soledad Gallego Melcon, Lucas Moreno, Miguel F Segura
Structural disruption of BAF chromatin remodeller impairs neuroblastoma metastasis by reverting an invasiveness epigenomic program. Molecular cancer 21 (1) (2022)
Marta Pérez-Hernández, Cristina Cuscó, Cristina Benítez-García, Joaquin Bonelli, Marina Nuevo-Fonoll, Aroa Soriano Fernandez, David Martínez-García, Alain Arias-Betancur, María García-Valverde, Miguel F Segura, Roberto Quesada, Josep Rocas, Vanessa Soto-Cerrato, Ricardo Pérez Tomás
Multi-Smart and Scalable Bioligands-Free Nanomedical Platform for Intratumorally Targeted Tambjamine Delivery, a Difficult to Administrate Highly Cytotoxic Drug. Biomedicines 9 (5) (2021)
Ariadna Boloix, Natalia Feiner-Gracia, Mariana Köber, Javier Repetto, Rosa Pascarella, Aroa Soriano Fernandez, Marc Masanas, Nathaly Segovia, Guillem Vargas-Nadal, Josep Merlo-Mas, Dganit Danino, Inbal Abutbul-Ionita, Laia Foradada, Josep Roma, Alba Córdoba, Santi Sala, Josep Sánchez de Toledo, Soledad Gallego Melcon, Jaume Veciana, Lorenzo Albertazzi, Miguel F Segura, Nora Ventosa
Engineering pH-Sensitive Stable Nanovesicles for Delivery of MicroRNA Therapeutics. Small (Weinheim an der Bergstrasse, Germany) (2021)
Irina Giralt, Gabriel Gallo-Oller, Natalia Navarro, Patricia Zarzosa, Guillem Pons, Ainara Magdaleno, Miguel F Segura, Constantino Sábado, Raquel Hladun, Diego Arango, José Sánchez de Toledo, Lucas Moreno, Soledad Gallego Melcon, Josep Roma
Dickkopf-1 Inhibition Reactivates Wnt/β-Catenin Signaling in Rhabdomyosarcoma, Induces Myogenic Markers In Vitro and Impairs Tumor Cell Survival In Vivo. International journal of molecular sciences 22 (23) (2021)
Mireia Olivan, Marta Garcia, Leticia Suárez, Marc Guiu, Laura Gros, Olga Méndez, Marina Rigau, Jaume Reventós, Miguel F Segura, Inés de Torres, Jacques Planas, Xavier de la Cruz, Roger R Gomis, Juan Morote, Ruth Rodriguez-Barrueco, Anna Santamaria
Loss of microRNA-135b Enhances Bone Metastasis in Prostate Cancer and Predicts Aggressiveness in Human Prostate Samples. Cancers 13 (24) (2021)
Carlos Jiménez, Roberta Antonelli, Marc Masanas, Aroa Soriano Fernandez, Laura Devis-Jauregui, Jessica Camacho, Ainara Magdaleno, Gabriela Guillén, Raquel Hladun, Luz Jubierre, Josep Roma, David Llobet-Navàs, Josep Sánchez de Toledo, Lucas Moreno, Soledad Gallego Melcon, Miguel F Segura
Neuronal Differentiation-Related Epigenetic Regulator ZRF1 Has Independent Prognostic Value in Neuroblastoma but Is Functionally Dispensable In Vitro. Cancers 13 (19) (2021)
Irina Giralt, Gabriel Gallo-Oller, Natalia Navarro, Patricia Zarzosa, Guillem Pons, Ainara Magdaleno, Miguel F Segura, José Sánchez de Toledo, Lucas Moreno, Soledad Gallego, Josep Roma
Dickkopf Proteins and Their Role in Cancer: A Family of Wnt Antagonists with a Dual Role. Pharmaceuticals (Basel, Switzerland) 14 (8) (2021)
Miguel F Segura, Aroa Soriano, Josep Roma, Olga Piskareva, Carlos Jiménez, Ariadna Boloix, Jamie I Fletcher, Michelle Haber, Juliet C Gray, Leonor Cerdá-Alberich, Blanca Martínez de Las Heras, Adela Cañete, Soledad Gallego, Lucas Moreno
Methodological advances in the discovery of novel neuroblastoma therapeutics. Expert opinion on drug discovery (2021)
Roberta Antonelli, Carlos Jiménez, Misha Riley, Tiziana Servidei, Riccardo Riccardi, Aroa Soriano, Josep Roma, Elena Martínez-Saez, Maurizio Martini, Antonio Ruggiero, Lucas Moreno, Josep Sánchez de Toledo, Soledad Gallego, Jordi Bové, Jacob M Hooker, Miguel F Segura
CN133, a Novel Brain-Penetrating Histone Deacetylase Inhibitor, Hampers Tumor Growth in Patient-Derived Pediatric Posterior Fossa Ependymoma Models. Cancers 12 (7) (2020)
Alfonso Parrilla, Marta Barber, Blanca Majem, Josep Castellví, Juan Morote, José Luis Sánchez, Asunción Pérez-Benavente, Miguel F Segura, Antonio Gil-Moreno, Anna Santamaria
Aurora Borealis (Bora), Which Promotes Plk1 Activation by Aurora A, Has an Oncogenic Role in Ovarian Cancer. Cancers 12 (4) (2020)
Laia París-Coderch, Aroa Soriano Fernandez, Carlos Jiménez, Tatiana Erazo, Pau Muñoz-Guardiola, Marc Masanas, Roberta Antonelli, Ariadna Boloix, José Alfón, Héctor Pérez-Montoyo, Marc Yeste-Velasco, Carles Domènech, Josep Roma, Josep Sánchez de Toledo, Lucas Moreno, Jose Miguel Lizcano, Soledad Gallego Melcon, Miguel F Segura
The antitumour drug ABTL0812 impairs neuroblastoma growth through endoplasmic reticulum stress-mediated autophagy and apoptosis. Cell death & disease 11 (9) (2020)
Elena Coccia, Laura Planells-Ferrer, Raquel Badillos-Rodríguez, Marta Pascual, Miguel F Segura, Rita Fernández-Hernández, Joaquin López-Soriano, Eloi Garí, Eduardo Soriano, Bruna Barneda-Zahonero, Rana S Moubarak, M José Pérez-García, Joan X Comella
SIVA-1 regulates apoptosis and synaptic function by modulating XIAP interaction with the death receptor antagonist FAIM-L. Cell death & disease 11 (2) (2020)
Pau Muñoz-Guardiola, Josefina Casas, Elisabet Megías-Roda, Sònia Solé, Héctor Perez-Montoyo, Marc Yeste-Velasco, Tatiana Erazo, Nora Diéguez-Martínez, Sergio Espinosa-Gil, Cristina Muñoz-Pinedo, Guillermo Yoldi, Jose Luis Abad, Miguel F Segura, Teresa Moran, Margarita Romeo, Joaquim Bosch-Barrera, Ana Oaknin, Jose Alfón, Carles Domènech, Gemma Fabriàs, Guillermo Velasco, Jose Miguel Lizcano
The anti-cancer drug ABTL0812 induces ER stress-mediated cytotoxic autophagy by increasing dihydroceramide levels in cancer cells. Autophagy 17 (6) (2020)
Aroa Soriano, Marc Masanas, Ariadna Boloix, Núria Masiá, Laia París-Coderch, Olga Piskareva, Carlos Jiménez, Kai-Oliver Henrich, Josep Roma, Frank Westermann, Raymond L Stallings, Constantino Sábado, Josep Sánchez de Toledo, Anna Santamaria, Soledad Gallego, Miguel F Segura
Functional high-throughput screening reveals miR-323a-5p and miR-342-5p as new tumor-suppressive microRNA for neuroblastoma. Cellular and molecular life sciences : CMLS 76 (11) (2019)
Blanca Majem, Alfonso Parrilla, Carlos Jiménez, Leticia Suárez-Cabrera, Marta Barber, Andrea Marín, Josep Castellví, Gabriel Tamayo, Gema Moreno-Bueno, Jordi Ponce, Xavier Matias-Guiu, Francesc Alameda, Ignacio Romero, José Luis Sánchez, Asunción Pérez-Benavente, Sebastian Moran, Manel Esteller, Jaume Reventós, Marina Rigau, Antonio Gil-Moreno, Miguel F Segura, Anna Santamaría
MicroRNA-654-5p suppresses ovarian cancer development impacting on MYC, WNT and AKT pathways. Oncogene 38 (32) (2019)
Luz Jubierre, Carlos Jiménez, Eric Rovira, Aroa Soriano, Constantino Sábado, Luis Gros, Anna Llort, Raquel Hladun, Josep Roma, Josep Sánchez de Toledo, Soledad Gallego, Miguel F Segura
Targeting of epigenetic regulators in neuroblastoma. Experimental & molecular medicine 50 (4) (2018)
Ana Almazán-Moga, Patricia Zarzosa, Isaac Vidal, Carla Molist, Irina Giralt, Natalia Navarro, Aroa Soriano, Miguel F Segura, Arantza Alfranca, Javier García-Castro, José Sánchez de Toledo, Josep Roma, Soledad Gallego Melcon
Hedgehog Pathway Inhibition Hampers Sphere and Holoclone Formation in Rhabdomyosarcoma. Stem cells international 2017 (2017)
Andrea Feliciano, Yoelsis Garcia-Mayea, Luz Jubierre, Cristina Mir, Manuela Hummel, Josep Castellvi, Javier Hernández-Losa, Rosanna Paciucci, Irene Sansano, Yilin Sun, Santiago Ramón Y Cajal, Hiroshi Kondon, Aroa Soriano Fernandez, Miguel F Segura, Alex Lyakhovich, Matilde E LLeonart
miR-99a reveals two novel oncogenic proteins E2F2 and EMR2 and represses stemness in lung cancer. Cell death & disease 8 (10) (2017)
Jingyi Yu, Rong Lei, Xueqian Zhuang, Xiaoxun Li, Gang Li, Sima Lev, Miguel F Segura, Xue Zhang, Guohong Hu
MicroRNA-182 targets SMAD7 to potentiate TGFβ-induced epithelial-mesenchymal transition and metastasis of cancer cells. Nature communications 7 (2016)

Miguel F Segura.css-eqlu8i{font-size:small;padding-left:4px;} (Miguel Segura)

Publication Activity (10 Years)

Top Topics

Top Venues

Miguel F Segura (Miguel Segura)